✦ LIBER ✦

Long-term treatment of sulphonylurea-treated diabetics with the α-glucosidase inhibitor Bay g 5421 (Acarbose)

✍ Scribed by H. Vierhapper; P. Bratusch-Marrain; W. Waldhäusl

Publisher: Springer
Year: 1981
Tongue: English
Weight: 88 KB
Volume: 20
Category: Article
ISSN: 0012-186X
DOI: 10.1007/bf00252772

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of theα⁃ glucosidase-inhibitor BA

Effect of theα⁃ glucosidase-inhibitor BAY-g-5421 on blood glucose control of sulphonylurea-treated diabetics and insulin-treated diabetics

✍ G. Sachse; B. Willms 📂 Article 📅 1979 🏛 Springer 🌐 English ⚖ 340 KB

Improvement of metabolic control in insu

Improvement of metabolic control in insulin dependent diabetics treated with the α-glucosidase inhibitor Acarbose for two months

✍ J. Gérard; A. S. Luyckx; P. J. Lefebvre 📂 Article 📅 1981 🏛 Springer 🌐 English ⚖ 530 KB

The effects of theα-glucosidase inhibito

The effects of theα-glucosidase inhibitor BAY g 5421 (Acarbose) on meal-stimulated elevations of circulating glucose, insulin, and triglyceride levels in man

✍ I. Hillebrand; K. Boehme; G. Frank; H. Fink; P. Berchtold 📂 Article 📅 1979 🏛 Springer 🌐 English ⚖ 432 KB

Long-term effectiveness of a new α-gluco

Long-term effectiveness of a new α-glucosidase inhibitor (BAY m1099-miglitol) in insulin-treated Type 2 diabetes mellitus

✍ Mitrakou, A.; Tountas, N.; Raptis, A.E.; Bauer, R.J.; Schulz, H.; Raptis, S.A. 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB 👁 1 views

In a double-blind, randomized study, miglitol (BAY m 1099), an ␣-glucosidase inhibitor, 100 mg tds or placebo was given orally with meals for a period of 24 weeks in 117 patients with Type 2 (non-insulin-dependent) diabetes mellitus (DM) treated with insulin. Fasting and 1 h postprandial plasma gluc

The effects of theα-glucosidase inhibito

The effects of theα-glucosidase inhibitor BAY g 5421 (Acarbose) on postprandial blood glucose, serum insulin, and triglyceride levels: Dose-time-response relationships in man

✍ I. Hillebrand; K. Boehme; G. Frank; H. Fink; P. Berchtold 📂 Article 📅 1979 🏛 Springer 🌐 English ⚖ 433 KB

Effects of the α-glucosidase inhibitor a

Effects of the α-glucosidase inhibitor acarbose on the development of long-term complications in diabetic animals: pathophysiological and therapeutic implications

✍ Werner Creutzfeldt 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB 👁 1 views

Short-term studies with acarbose have demonstrated its ef®cacy in reducing postprandial blood glucose levels and glycated haemoglobin (HbA 1c ) levels. These effects would be expected to translate into improvements in long-term complications of diabetes, but such data are not yet available due to th